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Abstract
COVID-19 pandemic has led to major changes in the delivery of medical care around the globe. Many investigations
and elective procedures had to be rescheduled to decrease the risk of spreading the infection. Non-invasive cardiac
imaging studies are requested to guide appropriate cardiac care in a variety of urgent, semi-urgent, and elective procedures. This position statement of the Cardiac Imaging Working Group of the Saudi Heart Association provides
guidance into the protection of healthcare personnel, assessment of the indications of the imaging studies, and highlights consideration before, during, and after the study.
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1. Introduction

T

he declaration of Coronavirus disease 2019
(COVID-19) as a pandemic by the World
Health Organization (WHO) has led to signiﬁcant
consequences on health care delivery all over the
world. COVID-19 is highly infectious and has a
widely variable presentation ranging from severe
respiratory distress to no symptoms. Asymptomatic individuals, in particular, pose a high risk of
infection to healthcare personnel [1]. The risk of

COVID-19 transmission remains high, even
within a distance of 1.8 m [2]. Therefore, it is
imperative that non-urgent cases, where cardiac
imaging does not have a direct impact on patient
care, be postponed. Cases where cardiac imaging
signiﬁcantly impacts the management plan
should be performed with necessary precautions
to ensure the safety of the healthcare personnel
(see Fig. 1).
The purpose of this document is to ensure that
appropriate and timely cardiac imaging studies are
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Fig. 1. Scheduling cardiac scan while considering the safety of the healthcare workers during the COVID-19 pandemic. CT ¼ computed tomography;
CMR ¼ cardiac magnetic resonance; MRI ¼ magnetic resonance imaging.

available to guide the management of all patients,
whether or not they are COVID-19 infected, while
ensuring the safety of the healthcare workers in
particular technologists, nurses and imaging experts
during image acquisition.
This document provides guidance into the protection of healthcare personnel, assessment of the
indications of the imaging studies, and highlights
consideration before, during, and after the study. It
covers nuclear cardiac imaging, cardiac magnetic
resonance (CMR), and cardiac computed tomography (CCT). These modalities have less direct contact
with the patient compared to echocardiography
making it more favorable during the pandemic to
decrease the risk of infection to health care
personnel.

2. Protection of Healthcare Personnel
The general principles of minimizing transmission of infection should be observed at all times.
These recommendations include distancing, hand

hygiene, and ensuring the availability of personal
protective equipment (PPE). It is also recommended
to avoid overcrowding at the workplace and to work
remotely whenever feasible.
Healthcare personnel should follow institutional
and local infection control recommendations.
Healthcare personnel who perform imaging examinations and are in close or direct contact with the
patient should use PPE as recommended by the
WHO, including an isolation gown with ﬂuidresistant characteristics, a pair of gloves with
coverage over gown cuffs, and eye protection with
face shield [2]. The risk status of each patient should
be evaluated according to the Saudi Center for
Disease Prevention and Control (Saudi CDC) [3].
Airborne precautions, including N95/FFP2/FFP3
mask and goggles, should be used in cases with
conﬁrmed or high risk for COVID-19 infection. First
and foremost, it is essential to consider the potential
risk of transmission of the infection to patients when
evaluating the indication for the imaging study.
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Table 1. Urgency level of the indications for non-invasive cardiac imaging.
Indication

Urgency Level

CCTA

CMR

Nuclear Imaging

Coronary Artery
disease

Urgent (1e7 days)a

1. Patient presenting to ED with
chest pain or low-risk NSTEMI/
UA
2. Quadruple rule out (CAD,
PE, late iodine enhancement
for myocarditis & pulmonary
inﬁltrates)

1. Stress CMR for patient
presenting to ED with chest
pain or low-risk NSTEMI/UA
2. Evaluation of viability in
patients with ongoing
symptoms undergoing
possible CABG
3. Diagnosis of
Myocarditis and MINOCA

Elective (4e8 weeks)

1. Evaluation of stable chest pain
2. Evaluation of congenital
anomalies

1. Evaluation of stable chest
pain
2. Evaluation of ischemia
after revascularization
3. Evaluation of medical
therapy when
revascularization is not
urgent
4. Evaluation of viability in
stable patients

1. Patient presenting to
ER with Chest pain or
low-risk NSTEMI/UA
2. Evaluation of chest
pain in moderate-high
likelihood CAD
3. Pre-operative
evaluation of patients
with moderate to highrisk CAD
4. Evaluation of chest
pain in patients with
high risk for contractinduced nephropathy.
5. Evaluation of
viability in patients
with ongoing
symptoms undergoing
possible CABG
1. Evaluation of stable
chest pain
2. Evaluation of
ischemia after
revascularization
3. Evaluation of
medical therapy when
revascularization is not
urgent
4. Evaluation of
viability in stable
patients

Urgent (1e7 days)a

Evaluation of acute aortic
syndrome (Dissection/Aneurysm)

Elective (4e8 weeks)

Follow up of aortic aneurysm

Urgent (1e7 days)a

1. Evaluation of thrombosed
valve
2. Evaluation of endocarditis
3. Evaluation of the left atrial
appendage
4. Evaluation for TAVR if
AVR is urgent
1. Evaluation prior TAVR,
TMVR, LAA closure
2. Pulmonary Vein
assessment for AF ablation
3. Congenital Heart diseases
1. Evaluation of CAD in new
CHF patient
2. Evaluation of LV thrombus
3. Evaluation of LVAD

Evaluation of acute aortic
syndrome (Dissection/
Aneurysm)
Follow up of aortic aneurysm
(CT is preferred)
1. Evaluation of the degree of
valvular regurgitations in
cases requiring urgent
intervention

Aortopathy

Valvular & structural
heart diseases

Elective (4e8 weeks)

Heart Failure

Urgent (1e7 days)a

Elective (4e8 weeks)

Follow up of aortitis
1. Evaluation of
prosthetic valve
endocarditis

1. Evaluation of
complications of endocarditis
2. Congenital Heart
diseases
1. Stress CMR Evaluation
new CHF with lowintermediate likelihood of
CAD
2. Evaluation of LV
thrombus
3. Evaluation of LVEF
4. Evaluation of the LVEF
before chemotherapy or
for follow up of
chemotherapy

Follow up of LVEF

1. Evaluation new CHF
with low-intermediate
likelihood of CAD
2. Evaluation of LV
thrombus
3. Evaluation of LVEF
4. Evaluation of the
LVEF before
chemotherapy or for
follow up of
chemotherapy
5. Evaluation of LVAD/
CEID endocarditis
Follow up of the LVEF
(continued on next page)

Table 1. (continued )
Indication

Urgency Level

CCTA

CMR

Nuclear Imaging

Arrhythmia and
sudden cardiac
death

Urgent (1e7 days)a

Anomalous origin of coronary
artery

1. Evaluation of ARVC
2. Evaluation of
sarcoidosis
1. Follow up of sarcoidosis
2. Follow up of HCM
Evaluation of cardiac tumors/
thrombus
Follow up of cardiac masses

1. Evaluation of
sarcoidosis

Elective (4e8 weeks)
Cardiac masses

Urgent (1e7 days)a
Elective (4e8 weeks)

Evaluation of cardiac tumors/
thrombus
Follow up of cardiac masses

1. Follow up of
sarcoidosis

ED: emergency department, NSTEMI/UA: Non-ST-elevation myocardial infarction/unstable angina; CABG: coronary artery bypass
grafting; MINOCA ¼ myocardial infarction with non-obstructive coronary artery disease; CAD: coronary artery disease; PE: pulmonary
embolism; TAVR: transcatheter aortic valve replacement; AVR: aortic valve replacement; TMVR: trans-catheter mitral valve replacement; LAA: Left atrial appendage; AF: atrial ﬁbrillation; CHF: congestive heart failure; LV ¼ left ventricle/ventricular; LVAD: left
ventricular assist device; LVEF: left ventricular ejection fraction; CEID: cardiac implantable electronic device; ARVC: arrhythmogenic
right ventricular cardiomyopathy; HCM: hypertrophic cardiomyopathy.
a
Timing of performing the test should be individualized based on the acuity of each indication.

3. Consideration Before Patient Arrival to the
Test

and a priority list should be made to reschedule the
deferred cases in a timely fashion.

The indication of each test should be reviewed by
the imaging expert and discussed with the treating
physician by the appropriate use criteria of each
modality [4e6]. Once the test is considered appropriate, then the level of urgency should be determined (Table 1). The indications are subdivided into
two groups, urgent indications (where the test
should be performed with a week) and semi-urgent
indications (where the test should be performed
within two weeks). As mentioned earlier, all the
elective cases should be deferred until the pandemic
resolves. The decision to perform the test should be
based on the urgency, availability of the test, the
possibility of deferring the test without affecting
patient care, and ﬁnally, the time frame for performing the deferred tests. In COVID-19 conﬁrmed
cases and persons under investigation with a high
index of suspicion, the indication of the test should
be discussed with the main responsible physician
(MRP), and the test should be performed if it is
absolutely necessary and has an immediate impact
on the management plan.
If the test is deemed urgent, it should be performed with the appropriate precautions based on
the patient status. Likewise, a semi-urgent test can
be scheduled within two weeks. The patient should
be called before the day of the test, and his/her risk
should be reassessed according to the most updated
Saudi CDC deﬁnitions.
All routine requests should be reviewed and triaged according to how long it can be deferred
without affecting patient outcome. The rationale
behind deferring the tests should be documented,

4. Consideration During the Test
The patient should be interviewed again upon
arrival to the imaging suite for exposure and
symptoms of COVID-19. If feasible, a temperature
check by a non-contact thermometer is encouraged
before the patient enters the test location. Surgical
face mask should be worn by all patients in the
waiting areas and in the test location. Appropriate
distancing of around 2 m should always be
observed. Measures should be taken to minimize
the number of technologists and nurses in direct
contact with each patient. Whenever possible, patients who have been tested positive should bypass
the waiting or receiving areas and enter the examination room immediately, avoiding contact with any
other patient.
Short protocols are encouraged to minimize contact with the patient. The protocol should be tailored
to answer the question of the referring physician.
For scheduled stress tests, vasodilator stress testing
is preferred over those employing exercise to
decrease the chance of droplet and airborne exposure. Short vasodilator protocols such as regadenson should be utilized when possible.
A separate machine should be dedicated to
COVID-19 positive patients if feasible. Otherwise,
COVID-19 patients should be booked at the end of
the day. In studies conducted for COVID-19 positive
patients, at least one healthcare worker (preferably a
technologist) should have full PPE to position and
set up the patient in the scanner. Another technologist should remain in the control room and
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conﬁgure the acquisition protocol. The computer
workstation should not be accessed by anyone who
has been in the scanning room and in contact with
the patient. The imaging expert should remain in
the control room or remotely to monitor and interpret the study.

5. Consideration After the Test
Reading and reporting of the test should be performed through a remote system whenever
possible. The reporting should be done by the
assigned imaging expert. If multiple physicians are
required (trainees), then distancing should be
encouraged with telephone discussion whenever
possible. If a second opinion is required from
another expert colleague or the MRP, that should be
conducted remotely as well.

6. Terminal Cleaning of the Machine
The machine, blood pressure cuffs, ECG cables,
and reporting workstations, including the mouse
and keyboard, should be cleaned and disinfected
after each use. Doorknobs, table surfaces, and ﬂoors
should also be cleaned after each use.
After scanning a COVID-19 patient, the machine
should be cleaned per the local infection control
recommendations. The machine should be closed
for at least 1 h to allow for passive ventilation.
Thereafter, the room cab terminally cleaned and
closed for another hour before it can be used again.
Meticulous decontamination of all the equipment
that came in contact with a COVID-19 positive patient per the manufacturer's recommendations is
advised.

7. Conclusions
This document is a general statement about the
best practices for Carduac CT, Cardiac MRI and
nuclear cardiac imaging during the COVID-19
pandemic. . The choice of imaging including the
consideration of echocardiography should be
considered based on the availability of the modality
and expertise in individual hospitals. It is also
essential to be mindful that there may be a shortage
of some of the required material, such as
radioisotopes.

These recommendations are designed to assist in
management decisions only and do not replace
clinical judgment. Individualized case by case decisions are strongly advised, especially for elderly
and immunocompromised patients. Urgent cases of
COVID-19 conﬁrmed, or highly suspected cases
must be discussed with the imaging expert beforehand to determine the most suitable imaging modality and expedite reporting to facilitate patient
disposition.
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